Oral Treatment for Covid 19, Human Phase I Trials, page-129

Lastly the proof of little to no proof is in the announcements going back to 2013 if you care to read them.
The first big lot of spin started even before they had done the first in man cancer trial where they stated if the trial was successful they would explore the need for a partnership going forward.
This spin has continued from the many times they reported that the taste etc concerns had been overcome, which we know wasn't the case as this caused them to change from capsule to table.
They also announced that money being raised was to progress human trials (2018), they have also announced on many occasions up coming human trials, tables being produce for human trials. With Covid in July last year stated the next step would be to produce a document and Dxecutive summary which would lead to in human trials, we know that this wasn't the next step as we then had 360Labs research and now Leiden research.
They have also claimed to be working closely with Elanco but were surprised by refusal of option agreement, they claimed to be working closely with Leiden but didn't know about soluble issue, they claimed to be working closely with Sygnene but didn't know about the delay with material.

Now for your information I do believe in the science and also I have been in PAA since 2013 back then sp was around .01 and they did a 20 to 1 consolidation back in 2015